https://doi.org/10.4081/monaldi.2024.3259

Editorial Expression of Concern: Lipid-lowering therapy in patients with coronary heart disease: an Italian real-life survey. Results from the Survey on Risk FactOrs and CardiovascuLar secondary prevention and drug strategieS (SOFOCLES) in Italy

Early Access
Published: November 12, 2024
Expression of Concern, SOFOCLE Study
Abstract Views: 419
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

The Monaldi Archives for Chest Disease Editors
editor@monaldi-archives.org
Monaldi Archives for Chest Disease, Italy.

The Editors and the Publisher have been alerted to concerns about this article (DOI: 10.4081/monaldi.2024.2972 ), and an investigation is in progress. In the interim, we alert readers that these concerns have been raised.

This Expression of Concern will remain in place until the investigation is completed and any further needs for appropriate action have been taken.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC
.

How to Cite

Monaldi Archives for Chest Disease Editors, The. 2024. “Editorial Expression of Concern: Lipid-Lowering Therapy in Patients With Coronary Heart Disease: An Italian Real-Life Survey. Results from the Survey on Risk FactOrs and CardiovascuLar Secondary Prevention and Drug StrategieS (SOFOCLES) in Italy”. Monaldi Archives for Chest Disease, November. https://doi.org/10.4081/monaldi.2024.3259.
Copyright (c) 2024 The Author(s) Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.